Establishing secure connection…Loading editor…Preparing document…

Healthcare Clinical Research Form

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE CLINICAL RESEARCH FORM

Participant Information

Date of Birth:   Gender:

Phone:   Email:

Insurance Information

Policy Number:   Group Number:

Medical History

Study Details

Protocol Number:   Principal Investigator:

Anticipated Duration of Participation:   Expected Number of Visits:

Risks, Benefits, and Alternatives

I acknowledge that the investigator has explained the purpose of the study, the procedures I will undergo, the reasonably foreseeable risks and discomforts, and any potential direct benefits to me. Potential risks include, but are not limited to, physical injury, adverse reaction to study interventions, psychological stress, and breach of confidentiality. Potential benefits may include clinical monitoring, access to investigational treatments, and contribution to medical knowledge. There may be alternatives to participation, including standard medical care without enrollment in this study.

Voluntary Participation and Withdrawal

Participation is voluntary. I understand that I may refuse to participate or withdraw from the study at any time without penalty or loss of benefits to which I am otherwise entitled. If I withdraw, the investigator may retain and use data collected up to the time of withdrawal as specified below, unless I explicitly request destruction of identifiable data.

Authorization for Use and Disclosure of Protected Health Information (PHI)

By signing below, I authorize the release of my protected health information to the research team for purposes of this study, including but not limited to medical records, laboratory results, imaging, and pathology. Information disclosed may be used for study conduct, safety monitoring, regulatory reporting, and publication in a de-identified manner. The recipient of the information may not be required to comply with privacy protections beyond those in this authorization.

Purpose of Disclosure:

I authorize disclosure of my PHI to:

I understand that I may revoke this authorization in writing at any time, except to the extent that action has already been taken in reliance upon it. If I revoke the authorization, the withdrawal will not affect actions already taken based on this authorization prior to receipt of my written revocation.

Compensation, Costs, and Injury

Will I receive compensation for participation?   Yes   No

If yes, describe compensation or reimbursement:

I acknowledge that the investigator has explained financial obligations, if any, and the process for reporting and treating research-related injury. I understand that receiving medical care for research-related injury may result in charges that may or may not be covered by insurance.

Confidentiality and Data Use

All reasonable measures will be taken to protect my confidentiality. Identifiable data will be accessed only by authorized study personnel. My data may be used in future research in a de-identified format. If data are shared with third parties for research purposes, identifiers will be removed unless I provide separate consent for identifiable sharing.

Participant Attestations

By checking the box below and signing, I confirm that the information I have provided is true and complete to the best of my knowledge, I have had an opportunity to ask questions, and those questions have been answered to my satisfaction. I understand the statements above and agree to participate under the terms described.

I consent to participate in this research study: I consent

Additional Permissions

I authorize the use of photographs, recordings, or other media for research and educational purposes only if checked: Yes

Signature

Participant Name:

Signature:

Date:

If signed by a legal representative or guardian on behalf of the participant, state your relationship and authority to sign:

Relationship to Participant:

Authority / Basis for Representation:

Enter text✕

What the Healthcare Clinical Research Form Is and where it fits

The Healthcare Clinical Research Form is a standardized document used to collect participant information, informed consent, medical history, and study-specific data for clinical trials and observational research. It typically records identifying details, eligibility screening, consent language, HIPAA authorization, protocol identifiers, and fields for adverse-event reporting. The form supports regulatory review, source-data verification, and audit trails required by IRBs and sponsors. Electronic versions must preserve evidence of consent, signer attribution, and a reproducible record to meet ESIGN (15 U.S.C. ch. 96, 2000) and applicable state law requirements.

Why a clear, compliant Clinical Research Form matters

A correctly completed form protects participant rights, documents consent, and ensures data quality for analysis and regulatory inspection. Accurate forms reduce protocol deviations, speed IRB review, and support HIPAA-compliant recordkeeping under 45 CFR §164.530(j).

Why a clear, compliant Clinical Research Form matters

Who typically completes and signs this form

Users span clinical teams, regulatory staff, and participants; roles determine which fields they complete.

  • Clinical staff — research nurses or coordinators complete eligibility, vitals, and data-entry sections.
  • Principal investigators — verify consent, sign investigator attestations, and confirm protocol adherence.
  • Participants or legally authorized representatives — provide informed consent and sign the authorization sections.

Understanding role responsibilities reduces errors and ensures the right signatures and timestamps appear in the record.

Stepwise process to complete the form correctly

Follow a consistent, documented sequence from screening through signature to ensure complete, auditable records.

  • 01
    1. Verify Eligibility: Confirm inclusion/exclusion criteria before enrollment.
  • 02
    2. Review Consent: Read consent language aloud and answer participant questions.
  • 03
    3. Collect Identifiers: Record full name, DOB, MRN, and contact details.
  • 04
    4. Sign and Date: Participant and investigator sign; capture timestamp.

Configuring an online workflow for the form

Set electronic fields and authentication to mirror the paper process and satisfy audit requirements.

Field Configuration
Authentication Email link plus SMS code for signer verification
Conditional Logic Show relevant medical-history fields only when applicable
Attachments Required Attach consent PDF and source ID image if needed
Retention Setting Set to 6 years for HIPAA-regulated records

Where completed forms should be routed and archived

Design routing rules so each completed form reaches the sponsor, IRB, and institutional archive automatically.

  • To Sponsor: Send final signed copy to sponsor's clinical trial master file
  • To IRB: Submit signed consent and consent log to the IRB per their SOP
  • To EDC: Upload source data and PDF to the electronic data capture system
  • To Archive: Store secure copy in institutional records with retention metadata

Technical considerations for eSubmission and integrations

Confirm the e-signature platform supports HIPAA security, audit trails, and the integrations you need.

  • Integrations: Salesforce, NetSuite, and EDC systems
  • Formats: PDF, DOCX, and exported audit logs
  • Security: AES-256 at rest; TLS 1.2/1.3 in transit

Essential components of a professional Clinical Research Form

A complete form groups participant data, study identifiers, consent text, clinical assessments, safety reporting, and signature evidence for regulatory and audit review.

Consent Section

Clear, IRB-approved consent language with checkboxes for each permission and a HIPAA authorization block when PHI is disclosed.

Demographics

Structured fields for name, DOB, sex, race, contact information, and institution MRN to support consistent data capture.

Medical History

Targeted past-medical and medication fields that match protocol screening criteria to reduce downstream queries.

Protocol Data

Study visit ID, visit date, procedure codes, and any protocol deviation notation for monitoring and audit trails.

Adverse Events

Templated AE/SAE capture with onset date, severity, relationship assessment, and reporter contact information.

Signatures & Audit

Signer name, role, date, time, IP or authentication method, plus a tamper-evident audit trail for each action.

Key data elements and security-related fields

Protected Health Information: Limit PHI to necessary elements
Study ID: Unique protocol identifier
Participant ID: Study-assigned subject number
Consent Status: Yes/No with timestamp
Investigator Details: Name, role, contact
Audit Trail: Timestamps and signer attribution

Legal and operational risks of incorrect or incomplete forms

Invalid Consent: May render subject data unusable for primary analysis
HIPAA Violations: Potential enforcement and corrective-action obligations
Regulatory Findings: IRB or FDA inspection observations and required remediation
Data Integrity Loss: Unreliable datasets leading to rework
Legal Exposure: Increased sponsor or institutional liability
Enrollment Delays: Study timelines and budgets can be adversely impacted

Common preparation mistakes to avoid

  • Leaving consent checkboxes unchecked or incomplete, which invalidates the consent event and requires reconsent.
  • Mismatched names or identifiers between consent and source records, causing audit queries and possible data exclusion.
  • Failing to record the signer's role (participant vs. legally authorized representative), which affects consent validity.
  • Using unsecured email or shared drives for signed forms, increasing the risk of unauthorized access and HIPAA exposure.

Key timelines and reporting expectations

Track IRB, sponsor, and regulatory deadlines actively; safety and retention timelines have legal implications.

IRB Approval Date:

IRB approval must precede participant enrollment

Enrollment Window:

Record visit dates within protocol-defined windows

SAE Reporting:

Report serious adverse events per protocol and sponsor timelines, often within 24–72 hours

Data Lock:

Complete source reconciliation before database lock for analysis

Retention Schedule:

Retain records per law and sponsor contract; see retention timeline

Real-world examples of form usage and outcomes

These examples illustrate practical deployments and outcomes from clinical and institutional settings.

Fertility Center Implementation

A clinic standardized consent forms across sites to reduce errors and speed enrollment.

  • The team used e-signatures for home consenting.
  • Results included improved tracking and fewer missing signatures during monitoring visits, easing audits and participant follow-up.

Academic Trial Streamline

A university integrated signed forms directly into their EDC to shorten data entry.

  • Investigators used conditional fields for minor assent.
  • The approach reduced transcription errors and accelerated data lock timelines for interim analyses.

Pricing and feature comparison of popular eSignature vendors

Compare starting prices and key capabilities relevant to clinical research forms. Vendor feature sets and plan details vary by agreement and should be confirmed with each provider.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial, no credit card Varies by plan Varies by plan Varies by plan Varies by plan
Bulk Send Yes (premium tier) Yes Yes Yes Varies by plan
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No
Envelope Cap No envelope cap 100 envelopes/user/year Varies by plan Varies by plan Varies by plan

Frequently asked questions about the Healthcare Clinical Research Form

Answers to common questions about signatures, compliance, corrections, and storage for clinical research forms.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users